Antibiotics, gut microbiota, environment in early life and type 1 diabetes

被引:33
作者
Hu, Youjia [1 ]
Wong, F. Susan [2 ]
Wen, Li [1 ]
机构
[1] Yale Univ, Sch Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA
[2] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, S Glam, Wales
关键词
Gut microbiota; Neonatal immune response; Type; 1; diabetes; Immune regulation; RECURRENT CLOSTRIDIUM-DIFFICILE; SEGMENTED FILAMENTOUS BACTERIA; GRAM-NEGATIVE BACTERIA; INTESTINAL MICROBIOTA; NOD MICE; IMMUNE-RESPONSES; ULCERATIVE-COLITIS; T-CELLS; DIFFERENTIALLY INFLUENCE; AKKERMANSIA-MUCINIPHILA;
D O I
10.1016/j.phrs.2017.01.034
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The gut microbiota interact with innate immune cells and play an important role in shaping the immune system. Many factors may influence the composition of the microbiota such as mode of birth, diet, infections and medication including antibiotics. In diseases with a multifactorial etiology, like type 1 diabetes, manipulation and alterations of the microbiota in animal models have been shown to influence the incidence and onset of disease. The microbiota are an important part of the internal environment and understanding how these bacteria interact with the innate immune cells to generate immune tolerance may open up opportunities for development of new therapeutic strategies. In this review, we discuss recent findings in relation to the microbiota, particularly in the context of type 1 diabetes. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 123 条
[1]   Natural history of type 1 diabetes [J].
Achenbach, P ;
Bonifacio, E ;
Koczwara, K ;
Ziegler, AG .
DIABETES, 2005, 54 :S25-S31
[2]   Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice [J].
Alam, C. ;
Bittoun, E. ;
Bhagwat, D. ;
Valkonen, S. ;
Saari, A. ;
Jaakkola, U. ;
Eerola, E. ;
Huovinen, P. ;
Hanninen, A. .
DIABETOLOGIA, 2011, 54 (06) :1398-1406
[3]   Alterations in Intestinal Microbiota Correlate With Susceptibility to Type 1 Diabetes [J].
Alkanani, Aimon K. ;
Hara, Naoko ;
Gottlieb, Peter A. ;
Ir, Diana ;
Robertson, Charles E. ;
Wagner, Brandie D. ;
Frank, Daniel N. ;
Zipris, Danny .
DIABETES, 2015, 64 (10) :3510-3520
[4]  
Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.01.06.db05-0189
[5]   Changes of gut microbiota and immune markers during the complementary feeding period in healthy breast-fed infants [J].
Amarri, S. ;
Benatti, F. ;
Callegari, M. L. ;
Shahkhalili, Y. ;
Chauffard, F. ;
Rochat, F. ;
Acheson, K. J. ;
Hager, C. ;
Benyacoub, J. ;
Galli, E. ;
Rebecchi, A. ;
Morelli, L. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2006, 42 (05) :488-495
[6]  
[Anonymous], J DIABETES RES, DOI DOI 10.1155/2016/7569431
[7]   The stages of type 1A diabetes [J].
Babaya, N ;
Nakayama, M ;
Eisenbarth, GS .
AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 :194-204
[8]   The Hygiene Hypothesis: An Explanation for the Increased Frequency of Insulin-Dependent Diabetes [J].
Bach, Jean-Francois ;
Chatenoud, Lucienne .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (02)
[9]   Fecal Microbiota Transplantation in Patients With Cancer Undergoing Treatment [J].
Blackburn, Lisa M. ;
Bales, Andrea ;
Caldwell, Mary ;
Cordell, Lee ;
Hamilton, Susan ;
Kreider, Haley .
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2015, 19 (01) :111-114
[10]   Genetics, pathogenesis and clinical interventions in type 1 diabetes [J].
Bluestone, Jeffrey A. ;
Herold, Kevan ;
Eisenbarth, George .
NATURE, 2010, 464 (7293) :1293-1300